Logo

    Using Novalung to Treat Respiratory and Cardiac Failure with Dr. David Thompson

    enJune 08, 2021
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    A year ago, the FDA cleared a product for use in the U.S. called Novalung®, an extracorporeal membrane oxygenation system (ECMO). Listen as Dr. David Thompson, Vice President and Medical Director of Critical Care for the Renal Therapies Group, a division of Fresenius Medical Care North America, joins Field Notes to discuss successful experiences with the first ECMO system-FDA cleared for long-term use over six hours in patients with acute respiratory or acute cardiopulmonary failure.

    Recent Episodes from Field Notes

    Episode 42: An Update on Transplant Medicine with Dr. Benjamin Hippen

    Episode 42: An Update on Transplant Medicine with Dr. Benjamin Hippen

    April is National Donate Life Month, and during this time, we focus on raising awareness about transplantation and donation honor the people who have saved lives through the gift of donation. Tune in for this special episode today for an update on the latest in transplant medicine. Transplantation is the best method of treatment for many people with end stage kidney disease, when available and accessible. As a company, we prioritize expanding access to kidney transplantation and work to reduce the challenges facing patients as they work towards getting transplanted.

    Field Notes
    enMay 01, 2023
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io